Heart block is a disease of the electrical system of the heart that controls the rate and rhythm of the heart. A heart block occurs if there is slowed and disturbed electrical signals while travelling to the heart. People have inherited congenital heart blocks as well as acquired heart blocks that develop after birth. Based on the working of electric signal, heart block is of two types: partial heart block and complete heart block. In partial heart block, the electrical signals are blocked partially i.e., their arrival to the heart is delayed. In complete heart block, signal transmission gets blocked completely. Increase in the number of patients suffering from one or other heart block is projected to drive the global heart block treatment market. Additionally, age plays a crucial role in the development of heart block. Older the people higher the risk of acquiring heart stroke. Hence, aging population propels the global market. The World Health Organization (WHO) estimated that around 524 million people were old in 2010 and nearly 2 billion people will belong to the geriatric population by 2050. Moreover, increase in incidence of hypothyroidism fuels the growth of the global heart block treatment market. This is because people with hypothyroidism easily develop heart blocks.
The global heart block treatment market can be segmented based on type. In terms of type, the market can be classified into first degree heart block, second degree heart block, and third degree heart block. In first-degree heart block, electrical signals are slowed as they move from atria (upper chamber of heart) to ventricles (lower chamber of heart). Usually, first-degree heart block does not cause any symptoms and hence do not require treatment. In second degree heart block, electrical signals are slowed in large degree between atria and ventricles. Sometimes, several signals do not reach the ventricles. If electrical signals do not reach the ventricles, these will not contract and pump blood to the lungs along with the rest of the body. Second degree heart blocks are of two types: Mobitz type I and Mobitz type II. In third degree heart block, none of the electrical signals reach the ventricles resulting in complete heart block. Pacemakers are used for the treatment of third-degree heart block and some cases of second-degree heart block.
Geographically, the global heart block treatment market can be segmented into North America, Latin America, Asia Pacific, Europe, and Middle East & Africa. In terms of revenue, North America is projected to account for significant share of the global market. This is due to government support, increase in incidence of heart block, rise in research & development expenditure, and technology advancements. Asia Pacific is the most promising market for heart block treatment due to large population with high unmet medical needs, developing health care infrastructure, rise in awareness, and increase in disposable income. The market in Latin America and Africa is still in a nascent stage. However, reforms in health care infrastructure have induced large number of players to focus on establishing and increasing customer base in countries in the Middle East.
Major players operating in the global heart block treatment market include Medtronic, Inc., Boston Scientific Corporation, Abbott, BIOTRONIK SE & Co. KG., and SORIN S.p.A.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.